UV7-22766-35511
3 vaccinations
4 coded responses
28 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 788 / TX
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-26
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
-
2021-03-17
Dose 2 — Pfizer-BioNTech
- 2021-03-17
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
-
2021-06-16
Survey response — 3 months, dose 2MedDRA: Exposure during pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Became pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-16
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-21
- 2021-09-15
-
2021-09-23
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-07
- 2021-10-14
- 2021-10-21
-
2021-10-28
Survey response — day 35, dose 3MedDRA: Arthralgia, Office visit — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: I have knee pain.....it's been there for approximately a month ago and continues to come and go. · Healthcare visit (other): Clinic visitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-11-01
-
2021-12-23
Survey response — 3 months, dose 3MedDRA: Meniscus injury — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Tear of the meniscusMedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2021-12-27
-
2021-12-30
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-24
Survey response — 6 months, dose 3MedDRA: Antiphospholipid syndrome, Pregnancy — Feeling: GoodFree text: I was diagnosed with APS (Antiphospholipid Syndrome during pregnancy only)MedDRA releases: 2024-11 · check-in free text available
- 2022-09-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech | |
| 3 | 2021-09-23 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-16 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-10-28 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-12-23 | Successful 2021-12-30 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 3 months, dose 2
Symptoms: Became pregnant
Release 10 — day 35, dose 3
Symptoms: I have knee pain.....it's been there for approximately a month ago and continues to come and go.
Healthcare visit (other): Clinic visit
Release 10 — 3 months, dose 3
Symptoms: Tear of the meniscus
Release 11 — 6 months, dose 3
Symptoms: I was diagnosed with APS (Antiphospholipid Syndrome during pregnancy only)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Antiphospholipid syndrome | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Exposure during pregnancy | ✓ | ✓ | ✓ |
| SD | Meniscus injury | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release